A global non-profit partnership that supports early-stage antibacterial R&D to address the rising threat of drug-resistant bacteria.
🔗 Visit our website: https://www.carb-x.org
CARB-X
Loading...
CARB-X is committed to supporting projects to address AMR. Each new approval demonstrates that scientific innovation can deliver advances against AMR, while reinforcing the need for continued investment to ensure the next generation of solutions reaches patients. 🧪
🔗 Learn more: bit.ly/4hs01bB
Apply now for the EDCTP Prizes 2027!
Researchers and teams in #Africa and #Europe will be awarded prizes recognizing their achievements in global health research and innovation. Applications are due Sept. 2. #IDSky 🧪
📘 Eligibility criteria: bit.ly/4v8uFwX
🔗 Apply here: bit.ly/4wUOSrW
CARB-X welcomes FDA approval of Zaynich for cUTI patients. This new tool to treat MDR infections demonstrates that breakthrough innovation can emerge from diverse ecosystems around the world – a reminder that addressing AMR requires supporting innovators wherever they are. #IDSky
🔗
CARB-X Alliance Director Elizabeth Amiott will discuss navigating diagnostic product development, including translational gaps and oversights, at the @advance-id.bsky.social webinar. ADVANCE-ID is holding an open call for rapid Dx targeting AMR. #IDSky 🧪
📅 June 23
⏰ 6 – 7PM SGT
🔗 bit.ly/4eukg8r
Join CARB-X Alliance Director Elizabeth Amiott at the Sepsis Alliance Unite for Sepsis Symposium for the panel discussion, “Sepsis Diagnostics and Therapies: From Innovation to Evidence." #IDSky 🧪
📅 Thursday, June 11
⏰ 10:30 – 11:30 AM ET
🔗 Register here: bit.ly/3QeoM2v
Check out the preliminary program for #GAMRIC2026, which will bring together global experts for high-level discussions on the future of AMR R&D and innovation. CARB-X team members are chairing and speaking in multiple sessions. #IDSky 🧪
📘 Program: bit.ly/4dwyHIl
🔗 Registration: bit.ly/4kE2oKV
CARB-X welcomes the new Global Action Plan on Antimicrobial Resistance, adopted by WHO Member States at #WHA79, which lays out the path forward for the next decade of global AMR action, recognizing the need for sustained investment, public-private partnerships, and more. #IDSky 🧪
🔗 bit.ly/3PF0Rcs
IFPMA convened global leaders during #WHA79 to discuss how innovation, partnerships, and investment strengthen health systems and economies. Thank you to Dr. Fink-Hooijer of DG HERA & Dr. Lobritz of Roche for highlighting CARB-X's work to advance antibacterial innovation. #IDSky 🧪
🔗 bit.ly/49j4HP3
AMR threatens modern medicine and health systems as we know it, CARB-X Executive Director Kevin Outterson shared at the World Economic Forum Annual Health Rountable 2026 on the sidelines of the World Health Assembly. #IDSky 🧪
🔗 bit.ly/4v25mg6
Join CARB-X Executive Director Kevin Outterson for a webinar panel discussion on innovative models for financing antimicrobial development, building on the Milken Institute's Financial Innovations Lab report. #IDSky 🧪
📅 May 28
⏰ 15:30 – 17:00 CEST
🔗 Register here: bit.ly/43q7i6c
